scholarly journals Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions

Oncogene ◽  
2009 ◽  
Vol 28 (34) ◽  
pp. 3009-3021 ◽  
Author(s):  
A Gualberto ◽  
M Pollak
Cells ◽  
2020 ◽  
Vol 9 (2) ◽  
pp. 441 ◽  
Author(s):  
Yvan Torrente ◽  
Pamela Bella ◽  
Luana Tripodi ◽  
Chiara Villa ◽  
Andrea Farini

The insulin-like growth factor 2 receptor (IGF2R) plays a major role in binding and regulating the circulating and tissue levels of the mitogenic peptide insulin-like growth factor 2 (IGF2). IGF2/IGF2R interaction influences cell growth, survival, and migration in normal tissue development, and the deregulation of IGF2R expression has been associated with growth-related disease and cancer. IGF2R overexpression has been implicated in heart and muscle disease progression. Recent research findings suggest novel approaches to target IGF2R action. This review highlights recent advances in the understanding of the IGF2R structure and pathways related to muscle homeostasis.


Apmis ◽  
2009 ◽  
Vol 117 (12) ◽  
pp. 861-869 ◽  
Author(s):  
MYUNG HEE CHANG ◽  
JEEYUN LEE ◽  
JOUNGHO HAN ◽  
YEON HEE PARK ◽  
JIN SEOK AHN ◽  
...  

2003 ◽  
Vol 2 (6) ◽  
pp. 52
Author(s):  
M.A Rochester ◽  
N.S Patel ◽  
G.O Hellawell ◽  
S.F Brewster ◽  
V.M Macaulay

2002 ◽  
Vol 35 ◽  
pp. 81-92 ◽  
Author(s):  
G.P. Ceda ◽  
E. Dall’aglio ◽  
I. Salimbeni ◽  
A. Rocci ◽  
F. Corradi ◽  
...  

2010 ◽  
Vol 19 (5) ◽  
pp. 631-639 ◽  
Author(s):  
Cesare Gridelli ◽  
Antonio Rossi ◽  
Maria Anna Bareschino ◽  
Clorinda Schettino ◽  
Paola Claudia Sacco ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document